Fortrea Holdings, Inc. (FTRE)
15.55
+0.41
(+2.71%)
USD |
NASDAQ |
Dec 11, 16:00
15.29
-0.26
(-1.67%)
Pre-Market: 08:58
Fortrea Holdings EPS Diluted (Quarterly): -0.1743 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| Humana, Inc. | 1.615 |
| Merck & Co., Inc. | 2.316 |
| Medpace Holdings, Inc. | 3.857 |
| Avantor, Inc. | -1.044 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.90M |
| Revenue (Quarterly) | 701.30M |
| Total Expenses (Quarterly) | 717.20M |
| Enterprise Value | 2.493B |
| Gross Profit Margin (Quarterly) | 14.70% |
| Profit Margin (Quarterly) | -2.27% |
| Earnings Yield | -72.55% |
| Normalized Earnings Yield | -30.29 |